AU2001266345A1 - Five-membered-ring compound - Google Patents

Five-membered-ring compound

Info

Publication number: AU2001266345A1
Authority: AU; Australia
Prior art keywords: membered; ring compound; compound; ring
Prior art date: 2000-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001266345A

Other versions

AU2001266345B2 (en

Inventor

Fujio Antoku

Hitoshi Fujita

Norio Fujiwara

Hajime Kawakami

Toshinari Sugasawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Pharma Co Ltd

Original Assignee

Sumitomo Dainippon Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-06-28

Publication date

2002-04-11

2001-06-28 Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd

2001-06-28 Priority claimed from PCT/JP2001/005540 external-priority patent/WO2002002542A1/en

2002-04-11 Publication of AU2001266345A1 publication Critical patent/AU2001266345A1/en

2006-03-02 Application granted granted Critical

2006-03-02 Publication of AU2001266345B2 publication Critical patent/AU2001266345B2/en

2006-03-02 Assigned to DAINIPPON SUMITOMO PHARMA CO., LTD. reassignment DAINIPPON SUMITOMO PHARMA CO., LTD. Request for Assignment Assignors: SUMITOMO PHARMACEUTICALS COMPANY

2014-10-09 Assigned to SUMITOMO DAINIPPON PHARMA CO., LTD. reassignment SUMITOMO DAINIPPON PHARMA CO., LTD. Request to Amend Deed and Register Assignors: Dainippon Sumitomo Pharma., Ltd.

2021-06-28 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001266345A 2000-06-30 2001-06-28 Five-membered-ring compound Ceased AU2001266345B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000198074		2000-06-30
JP2000-198074		2000-06-30
PCT/JP2001/005540 WO2002002542A1 (en)	2000-06-30	2001-06-28	Five-membered-ring compound

Publications (2)

Publication Number	Publication Date
AU2001266345A1 true AU2001266345A1 (en)	2002-04-11
AU2001266345B2 AU2001266345B2 (en)	2006-03-02

Family

ID=18696291

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2001266345A Ceased AU2001266345B2 (en)	2000-06-30	2001-06-28	Five-membered-ring compound
AU6634501A Pending AU6634501A (en)	2000-06-30	2001-06-28	Five-membered-ring compound

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU6634501A Pending AU6634501A (en)	2000-06-30	2001-06-28	Five-membered-ring compound

Country Status (15)

Country	Link
US (2)	US6919361B2 (en)
EP (2)	EP1300401B1 (en)
JP (1)	JP3785397B2 (en)
KR (2)	KR100758775B1 (en)
CN (2)	CN1944417A (en)
AT (1)	ATE451102T1 (en)
AU (2)	AU2001266345B2 (en)
CA (1)	CA2413000C (en)
CY (1)	CY1109863T1 (en)
DE (1)	DE60140748D1 (en)
DK (1)	DK1300401T3 (en)
ES (1)	ES2336425T3 (en)
PT (1)	PT1300401E (en)
TW (1)	TWI313266B (en)
WO (1)	WO2002002542A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002361117A1 (en) *	2001-12-28	2003-07-24	Sumitomo Pharmaceuticals Co., Ltd.	5-membered cyclic compounds
EP1348433A1 (en) *	2002-03-28	2003-10-01	Warner-Lambert Company LLC	Thiazol-2-yl-imine compounds as PDE-7 inhibitors
DE10254336A1 (en) *	2002-11-21	2004-06-03	Merck Patent Gmbh	carboxamides
JPWO2005000825A1 (en) *	2003-06-27	2006-08-03	住友製薬株式会社	Thiazolimines and oxazolimines
CN101790068B (en) *	2003-10-10	2012-05-30	夏普株式会社	Reproducing apparatus, reproducing method of vedio data
MY162179A (en) *	2004-04-01	2017-05-31	Elan Pharm Inc	Steroid sparing agents and methods of using same
EP1820504A1 (en) *	2004-11-15	2007-08-22	Taisho Pharmaceutical Co., Ltd	Imine compound
KR101278011B1 (en) *	2005-04-28	2013-06-27	다이닛본 스미토모 세이야꾸 가부시끼가이샤	Therapeutic agent for chronic obstructive pulmonary disease
JP2007015999A (en) *	2005-07-11	2007-01-25	Sumitomo Chemical Co Ltd	Method for producing iminothiazole compound
JPWO2007132546A1 (en) *	2006-05-11	2009-09-17	大日本住友製薬株式会社	Pharmaceuticals containing thiazole derivatives as active ingredients
US8841334B2 (en)	2006-05-31	2014-09-23	Abbvie Inc.	Compounds as cannabinoid receptor ligands and uses thereof
WO2007140439A2 (en)	2006-05-31	2007-12-06	Abbott Laboratories	Compounds as cannabinoid receptor ligands and uses thereof
EP2142522A1 (en)	2007-03-28	2010-01-13	Abbott Laboratories	1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
US7872033B2 (en)	2007-04-17	2011-01-18	Abbott Laboratories	Compounds as cannabinoid receptor ligands
MX2009012374A (en)	2007-05-18	2009-12-01	Abbott Lab	Novel compounds as cannabinoid receptor ligands.
KR100863239B1 (en)	2007-05-23	2008-10-15	한국과학기술연구원	Novel 2-imino-1,3-thiazoline compounds and T-type calcium channel inhibitors containing them
US9193713B2 (en)	2007-10-12	2015-11-24	Abbvie Inc.	Compounds as cannabinoid receptor ligands
WO2009131170A1 (en)	2008-04-25	2009-10-29	大日本住友製薬株式会社	Five-membered ring compound
KR20100134688A (en)	2008-04-25	2010-12-23	다이닛본 스미토모 세이야꾸 가부시끼가이샤	Novel 5-membered Ring Compounds
US8846730B2 (en)	2008-09-08	2014-09-30	Abbvie Inc.	Compounds as cannabinoid receptor ligands
US8859596B2 (en)	2008-09-16	2014-10-14	Abbvie Inc.	Compounds as cannabinoid receptor ligands
PA8854001A1 (en)	2008-12-16	2010-07-27	Abbott Lab	NEW COMPOUNDS AS CANABINOID RECEIVERS LIGANDS
WO2010111572A1 (en)	2009-03-27	2010-09-30	Abbott Laboratories	Compounds as cannabinoid receptor ligands
WO2014052831A1 (en) *	2012-09-28	2014-04-03	Xavier University Of Louisiana	Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE941288C (en) *	1950-10-31	1956-04-05	Goodrich Co B F	Process for the preparation of substituted 2-imino-4-thiazolines or of salts thereof or of substituted 2-aminothiazoles
EP0848059A1 (en)	1996-12-12	1998-06-17	Vetigen	Mammalian ICYP (Iodocyanopindolol) receptor and its applications
US7076307B2 (en) *	2002-05-09	2006-07-11	Boveja Birinder R	Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders
FR2796643B1 (en) *	1999-07-22	2005-04-29	Sod Conseils Rech Applic	2-ARYLIMINO-2,3-DIHYDROTHIAZOLES DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE
EP1237849A1 (en) *	1999-11-05	2002-09-11	University College London	Activators of soluble guanylate cyclase
US20030208212A1 (en) *	1999-12-07	2003-11-06	Valerio Cigaina	Removable gastric band
DE19959825C1 (en) *	1999-12-10	2001-07-26	Dorma Gmbh & Co Kg	Sliding wall with several wall elements that can be moved sideways
US6885888B2 (en) *	2000-01-20	2005-04-26	The Cleveland Clinic Foundation	Electrical stimulation of the sympathetic nerve chain
US6708064B2 (en) *	2000-02-24	2004-03-16	Ali R. Rezai	Modulation of the brain to affect psychiatric disorders
US6639077B2 (en) *	2000-03-23	2003-10-28	Merck Frosst Canada & Co.	Tri-aryl-substituted-ethane PDE4 inhibitors
US6684105B2 (en) *	2001-08-31	2004-01-27	Biocontrol Medical, Ltd.	Treatment of disorders by unidirectional nerve stimulation
US7054686B2 (en) *	2001-08-30	2006-05-30	Biophan Technologies, Inc.	Pulsewidth electrical stimulation
US7715924B2 (en) *	2002-02-01	2010-05-11	The Cleveland Clinic Foundation	Adjustable simulation device and method of using same
JP2005516697A (en) *	2002-02-01	2005-06-09	ザクリーブランドクリニックファウンデイション	Neural stimulation transmission device with independently movable transmission structure
US20050010262A1 (en) *	2002-02-01	2005-01-13	Ali Rezai	Modulation of the pain circuitry to affect chronic pain
US7689276B2 (en) *	2002-09-13	2010-03-30	Leptos Biomedical, Inc.	Dynamic nerve stimulation for treatment of disorders
US7292890B2 (en) *	2002-06-20	2007-11-06	Advanced Bionics Corporation	Vagus nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) *	2002-06-20	2004-01-22	Whitehurst Todd K.	Implantable microstimulators with programmable multielectrode configuration and uses thereof
US20040210270A1 (en) *	2002-07-26	2004-10-21	John Erickson	High frequency pulse generator for an implantable neurostimulator
US7209790B2 (en) *	2002-09-30	2007-04-24	Medtronic, Inc.	Multi-mode programmer for medical device communication
US7844338B2 (en) *	2003-02-03	2010-11-30	Enteromedics Inc.	High frequency obesity treatment
US7444183B2 (en) *	2003-02-03	2008-10-28	Enteromedics, Inc.	Intraluminal electrode apparatus and method
US7613515B2 (en) *	2003-02-03	2009-11-03	Enteromedics Inc.	High frequency vagal blockage therapy
US20040172084A1 (en) *	2003-02-03	2004-09-02	Knudson Mark B.	Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7444184B2 (en) *	2003-05-11	2008-10-28	Neuro And Cardial Technologies, Llc	Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s)
US7149574B2 (en) *	2003-06-09	2006-12-12	Palo Alto Investors	Treatment of conditions through electrical modulation of the autonomic nervous system
US7263405B2 (en) *	2003-08-27	2007-08-28	Neuro And Cardiac Technologies Llc	System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
US7252090B2 (en) *	2003-09-15	2007-08-07	Medtronic, Inc.	Selection of neurostimulator parameter configurations using neural network
US7617002B2 (en) *	2003-09-15	2009-11-10	Medtronic, Inc.	Selection of neurostimulator parameter configurations using decision trees
US7184837B2 (en) *	2003-09-15	2007-02-27	Medtronic, Inc.	Selection of neurostimulator parameter configurations using bayesian networks
US7239926B2 (en) *	2003-09-15	2007-07-03	Medtronic, Inc.	Selection of neurostimulator parameter configurations using genetic algorithms
US7418292B2 (en) *	2003-10-01	2008-08-26	Medtronic, Inc.	Device and method for attenuating an immune response
CA2573785A1 (en) *	2004-07-20	2006-02-02	Medtronic, Inc.	Therapy programming guidance based on stored programming history

2001
- 2001-06-28 US US10/312,692 patent/US6919361B2/en not_active Expired - Fee Related
- 2001-06-28 EP EP01943850A patent/EP1300401B1/en not_active Expired - Lifetime
- 2001-06-28 CN CNA2006100818928A patent/CN1944417A/en active Pending
- 2001-06-28 CN CNB018146139A patent/CN100369903C/en not_active Expired - Fee Related
- 2001-06-28 DE DE60140748T patent/DE60140748D1/en not_active Expired - Lifetime
- 2001-06-28 AT AT01943850T patent/ATE451102T1/en active
- 2001-06-28 AU AU2001266345A patent/AU2001266345B2/en not_active Ceased
- 2001-06-28 KR KR1020027017947A patent/KR100758775B1/en not_active Expired - Fee Related
- 2001-06-28 AU AU6634501A patent/AU6634501A/en active Pending
- 2001-06-28 KR KR1020077015693A patent/KR100824156B1/en not_active Expired - Fee Related
- 2001-06-28 JP JP2002507796A patent/JP3785397B2/en not_active Expired - Fee Related
- 2001-06-28 WO PCT/JP2001/005540 patent/WO2002002542A1/en not_active Ceased
- 2001-06-28 EP EP05025661A patent/EP1669070A3/en not_active Withdrawn
- 2001-06-28 ES ES01943850T patent/ES2336425T3/en not_active Expired - Lifetime
- 2001-06-28 CA CA002413000A patent/CA2413000C/en not_active Expired - Fee Related
- 2001-06-28 PT PT01943850T patent/PT1300401E/en unknown
- 2001-06-28 DK DK01943850.6T patent/DK1300401T3/en active
- 2001-06-29 TW TW090115944A patent/TWI313266B/en not_active IP Right Cessation
2005
- 2005-04-22 US US11/111,845 patent/US7396842B2/en not_active Expired - Fee Related
2010
- 2010-03-02 CY CY20101100202T patent/CY1109863T1/en unknown

Publication	Publication Date	Title
AU2002225730A1 (en)	2002-05-27	Compounds
AU2002218266A1 (en)	2002-07-25	Novel indanylidene compounds
AU2001262847A1 (en)	2001-12-11	Language-understanding
AU2001254546A1 (en)	2001-11-07	Aminopiperidines
AU2000267458A1 (en)	2001-10-15	Hypercomputer
AU2001292518A1 (en)	2002-04-08	Novel compounds
AU2001266345A1 (en)	2002-04-11	Five-membered-ring compound
AU2001239310A1 (en)	2001-10-03	Decahydro-isoquinolines
AU2001279754A1 (en)	2002-01-30	Indoloquinazolinones
AUPQ661800A0 (en)	2000-05-04	Insulin-potentiating compounds
AU2001239765A1 (en)	2001-08-27	Novel compounds
AU2002211128A1 (en)	2002-04-22	Step-bike
AU2001246998A1 (en)	2001-10-23	Novel compounds
AU2001253362A1 (en)	2001-10-30	Novel compounds
AU2001265871A1 (en)	2001-11-07	Substituted sulfonylaminopyrimidines
AU2001258255A1 (en)	2001-11-29	Substituted benzoylcyclohexenones
AU2002231077A1 (en)	2002-07-01	Novel compounds
AU2001254731A1 (en)	2001-10-23	Substituted phenyluracils
AU2001256964A1 (en)	2001-10-08	Novel compounds
AU2002225724A1 (en)	2002-07-08	Motilide compounds
AU2002217285A1 (en)	2002-07-01	Compounds
AU2001230689A1 (en)	2001-08-07	Novel compounds
AUPQ575300A0 (en)	2000-03-16	New compound
AU2002216060A1 (en)	2002-06-11	Novel compounds
AU2002221923A1 (en)	2002-06-11	Novel compounds